Free Trial
NASDAQ:CRTX

Cortexyme (CRTX) Stock Price, News & Analysis

Cortexyme logo
$1.69 +0.06 (+3.68%)
As of 08/5/2025

About Cortexyme Stock (NASDAQ:CRTX)

Key Stats

Today's Range
$1.65
$1.75
50-Day Range
$1.04
$1.90
52-Week Range
$1.78
$40.66
Volume
419,779 shs
Average Volume
620,672 shs
Market Capitalization
$50.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter.

CRTX Stock News Headlines

Comparing Cortexyme (NASDAQ:CRTX) & NKGen Biotech (NYSE:NKGN)
Crism Thera Regulatory News
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.
See More Headlines

CRTX Stock Analysis - Frequently Asked Questions

Cortexyme's stock was trading at $1.85 at the beginning of the year. Since then, CRTX stock has decreased by 8.6% and is now trading at $1.69.

Cortexyme, Inc. (NASDAQ:CRTX) issued its earnings results on Monday, August, 9th. The biopharmaceutical company reported ($0.74) EPS for the quarter, beating analysts' consensus estimates of ($0.79) by $0.05.

Cortexyme (CRTX) raised $75 million in an IPO on Thursday, May 9th 2019. The company issued 4,400,000 shares at $16.00-$18.00 per share. BofA Merrill Lynch and Credit Suisse served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Shares of CRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cortexyme investors own include Alibaba Group (BABA), Enterprise Products Partners (EPD), NVIDIA (NVDA), Tesla (TSLA), Pfizer (PFE), Meta Platforms (META) and AT&T (T).

Company Calendar

Last Earnings
8/09/2021
Today
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:CRTX
CIK
1145404
Fax
N/A
Employees
55
Year Founded
2012

Profitability

EPS (Trailing Twelve Months)
($2.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$89.94 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-70.96%
Return on Assets
-63.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.92
Quick Ratio
9.92

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.97 per share
Price / Book
0.43

Miscellaneous

Outstanding Shares
30,151,000
Free Float
21,739,000
Market Cap
$50.96 million
Optionable
Not Optionable
Beta
1.40

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CRTX) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners